Cocrystal pharma announces a 1-for-12 reverse stock split

Bothell, wash., oct. 03, 2022 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp) (cocrystal or the company) announces that its board of directors has approved a 1-for-12 reverse stock split of the company's common stock. cocrystal's common stock is expected to begin trading on a split-adjusted basis at commencement of trading on tuesday, october 11, 2022.
COCP Ratings Summary
COCP Quant Ranking